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ABSTRACT
Objective: Palliative sedation is a method of symptom management frequently used in hospices
to treat uncontrolled symptoms at the end of life. There is a substantial body of literature on this
subject; however, there has been little research into the experiences of hospice nurses when
administering palliative sedation in an attempt to manage the terminal restlessness
experienced by cancer patients.
Method: Semistructured interviews were conducted with a purposive sample of seven hospice
nurses who had cared for at least one patient who had undergone palliative sedation within the
past year in a hospice in the south of England in the United Kingdom. A phenomenological
approach and Colaizzi’s stages of analysis were employed to develop themes from the data.
Results: Facilitating a “peaceful death” was the primary goal of the nurses, where through the
administration of palliative sedation they sought to enable and support patients to be
“comfortable,” “relaxed,” and “calm” at the terminal stage of their illness. Ethical dilemmas
related to decision making were a factor in achieving this. These were: medication decisions,
“juggling the drugs,” “causing the death,” sedating young people, the family “requesting”
sedation, and believing that hospice is a place where death is hastened.
Significance of results:Hospice nurses in the U.K. frequently encounter ethical and emotional
dilemmas when administering palliative sedation. Making such decisions about using palliative
sedation causes general discomfort for them. Undertaking this aspect of care requires
confidence and competence on the part of nurses, and working within a supportive hospice team
is of fundamental importance in supporting this practice.
KEYWORDS: Terminal restlessness, Palliative sedation, Ethical dilemmas, Peaceful death,
Hospice nurses
INTRODUCTION
Refractory symptoms, defined as symptoms that can-
not be adequately controlled despite aggressive ef-
forts to identify a tolerable therapy that does not
compromise consciousness (Cherny & Portenoy,
1994), are common in patients with advanced cancer
or other advanced diseases. Expressions such as “ter-
minal restlessness,” “terminal delirium,” and “termi-
nal agitation” are used interchangeably throughout
the literature. For the purposes of the present paper,
the term “terminal restlessness” will be employed to
describe this symptom. Terminal restlessness can de-
velop days or even weeks before death and manifests
in such persistent distressing physical symptoms as
pain, breathlessness, and agitated delirium (de
Graeff & Dean, 2007; Morita et al., 2005; Fainsinger
et al., 2000). Patients may also experience such
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psychological and spiritual/existential symptoms as
severe anxiety, anguish, and fear (Boston et al.,
2011; Lavoie et al., 2008). The most common ap-
proach taken to ameliorate terminal restlessness is
the provision of “terminal or palliative sedation.”
The European Association for Palliative Care consid-
ers the use of sedation to be an important and often
necessary symptom management measure in the
care of palliative care patients who are experiencing
uncontrollable symptoms that cause terminal
restlessness (Hauser & Walsh, 2009; Cherny & Rad-
bruch, 2009; de Graeff & Dean, 2007). Large differ-
ences in defining palliative sedation are reported in
the literature, as is reporting on the frequency of
symptoms and sedation practices between countries
and services. These are influenced by the country,
context, and clinical setting or site at which a study
was conducted (de Graeff & Dean, 2007; Beel et al.,
2002). There are also many inconsistencies with re-
gard to the prevalence and effect of sedation, food
and fluid intake, and the possible life-shortening ef-
fect of palliative sedation (Claessens et al., 2008).
BACKGROUND
Reporting on the types of medication used and the
frequency of the use of palliative sedation for patients
at the end of life also varies considerably across the
globe. Seale (2009) found that prescription of opioids
alone for palliative sedation occurred in a fifth of the
cases in the U.K. but was not reported by specialists
in palliative care. In 83% of cases from a study in the
Netherlands by Rietjens et al. (2008), sedation was
induced by benzodiazepines, often combined with
morphine. Benzodiazepines such as midazolam were
more likely to be used by palliative care specialists, a
practice supported by most guidelines (Rietjens
et al., 2008). Levomepromazine (a phenothiazine anti-
psychotic) and haloperidol (a butyrophenone antipsy-
chotic) are frequently prescribed in palliative care for
severe delirium/agitation during the last days of life
(Watson et al., 2009). Phenobarbitone is primarily
used for terminal sedation in intensive care units
and is rarely utilized in hospice, except under circum-
stances when a terminally agitated patient has not
responded to a previous drug regime (Gillon et al.,
2010; Cheng et al., 2002). A study in the Netherlands
by Swart et al. (2012) comparing palliative sedation
for cancer and noncancer patients reported that can-
cer patients were significantly more likely to receive
palliative sedation than noncancer patients. The re-
searchers speculated that this was probably due to
the less predictable course of noncancer diseases.
Although evidence-based clinical guidelines have
been proposed to manage symptoms in terminally
ill patients, clinicians regularly encounter ethical
dilemmas when administering palliative sedation
(Materstvedt & Bosshard, 2009, Morita et al., 2003;
2004). It has been shown that in some clinical situa-
tions where palliative sedation is required, health
professionals experience severe distress due to the
suffering of patients and their families, particularly
if there is limited success in managing symptoms
and decision making has been ambiguous (Brajtman
et al., 2006; Morita, 2004; Morita et al., 2004; Fain-
singer et al., 2000; Hallenbeck, 2000). Brajtman
(2003; 2005) argued that, although it is understood
that the use of palliative sedation for terminal rest-
lessness can have a profound effect on a patient’s
family, little is known about its impact on the team
of healthcare professionals.
In a study of 16 nurses’ experiences and their atti-
tudes about administering palliative sedation in hos-
pital settings in the Netherlands, sedation was used
primarily to address physical suffering in severely ill
patients. The nurses differed in how they perceived
the effects of palliative sedation on their patients.
Some believed it may have had a life-shortening ef-
fect and in some cases was justified in the interests
of comfort measures, while others thought it did not
shorten life and a third group believed that it was
close to euthanasia and had difficulty being involved
with the practice (Rietjens et al., 2007). A survey of
250 nurses in Flanders (Belgium) about their most
recent case of palliative sedation at the end of life re-
ported that 77% of nurses saw it mainly as a practice
intended to hasten death, and they believed that pal-
liative sedation had a life-shortening effect (Inghel-
brecht et al., 2011). Only 4% believed that it had
actually had no life-shortening effect. It was also re-
ported that nurses frequently made decisions to start
continuous palliative sedation jointly with physi-
cians and that physicians and patients’ relatives fre-
quently made decisions without the patient having a
role in the decision-making process. In contrast, a
prospective longitudinal study of sedation with 266
patients in Flemish palliative care units by Claes-
sens et al. (2011) showed that in all cases patients
gave consent to start palliative sedation. Nilsson
and Tengvall (2013) interviewed 14 nurses in a spe-
cialist palliative care unit in Sweden and identified
ethical concerns and also issues related to responsi-
bility, confidence, communication, and teamwork. A
study in Scotland by Zinn and Moriarty (2012) of
the experiences of nurses carrying out palliative se-
dation identified three themes—suffering, courage,
and peace—as representing how nurses believed
that palliative sedation was sometimes necessary
and appropriate to ensure a peaceful death.
Seymour and colleagues (2007) conducted inter-
views with 14 nurses, 11 doctors, and 10 researchers.
This research took place in the context of attention to
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euthanasia and assisted dying dialogues in the Neth-
erlands, Belgium, and the U.K. Interview data
from clinicians (doctors and nurses) revealed that
the administration of palliative sedation required
palliative care expertise, collaborative decision-mak-
ing processes and support systems, a good under-
standing of the ethical and legal frameworks, and
correct interpretation of suffering (Seymour et al.,
2007).
A study by Raus et al. (2014) that included the
same three countries as above focused on the emo-
tional impact of involvement in continuous sedation
by nurses, physicians, and relatives and their under-
standing of their moral responsibility. Interviews
were conducted with 57 physicians, 73 nurses, and
34 relatives. The settings from which participants
were recruited were: home, hospitals (mostly oncolo-
gy wards), and specialist palliative care settings (in-
cluding hospices). The emotional and moral impact
of continuously sedating a patient until death was
linked to how emotionally and physically close the
participants felt to the patient. Two types of closeness
were identified: “decisional closeness,” referring to
how close the participant felt to the patient, and
“causal closeness,” the perceived closeness to the
causal events of administering sedation. The re-
searchers also identified a theme of “stressing bene-
fits over harms,” where participants employed a
type of “balancing” reasoning to enable them to
cope with their feelings of moral responsibility.
The need for robust processes of ethical decision
making was also identified by Dean et al. (2014) fol-
lowing a retrospective review of patient records over
a 12-month period in 2009 at a Scottish hospice.
The authors identified inconsistencies and a lack
of clarity on what constituted “intolerable” or “refrac-
tory” suffering and proposed that the patient’s ability
to consent should be explicitly recorded, that the
team have a shared and explicit understanding of
the terminology and definitions of sedation, and
that formal mechanisms for support (such as clinical
supervision) are offered to staff. The development of
guidelines has become a focus and priority due to
concerns and uncertainty surrounding decision-
making dilemmas and the connotations and infer-
ences related to euthanasia and palliative sedation
(Abarshi et al., 2014; Schildmann & Schildmann,
2014; Cherny & Radbruch, 2009; Hauser & Walsh,
2009; Legemaate et al., 2007; Verkerk et al., 2007;
de Graeff & Dean, 2007; Engstro¨m et al., 2006).
The above studies on nurses’ experiences offer
some insight into the ethical issues that nurses face
when administering palliative sedation; however,
only a small sample of participants worked exclusive-
ly in hospice, and ethical dilemmas across all settings
were not largely addressed but did emerge.
RESEARCH DESIGN
A phenomenological approach was adopted in under-
taking our study. Phenomenology focuses on an indi-
vidual’s meaning-making as the key element of the
human experience and assumes that there is an un-
derlying structure and core meaning to shared expe-
riences and that these can be described, explained,
and interpreted (Patton, 2002). These meanings are
not always apparent to participants, so that re-
searchers have to interpret them from participants’
narratives (Lopez & Willis, 2004). An interpretive ap-
proach was taken that examined the subjective expe-
riences of the nurses with respect to palliative
sedation (Koch, 1995). This was informed by the
ideas of Heidegger (1962), who argued that the focus
of phenomenological inquiry should be the relation-
ship that the individual has to his or her lifeworld
and how participants are being-in-the-world.
Semistructured interviews were carried out with a
purposive sample of seven hospice nurses who had
cared for at least one patient who had undergone pal-
liative sedation within the past year at a hospice in
the south of England. Some 20 nurses working at
the hospice were invited to participate in the study,
but only 7 responded. All participants were female.
Their ages ranged from 24 to 62, with a median of
43 years. The length of time they had worked in pal-
liative care ranged from 7 months to 8 years.
Sample sizes in qualitative studies are usually
small, as the focus is to improve our understanding
of complex human issues rather than the generaliz-
ability of findings (Patton, 2002; Parahoo, 2006; Cres-
well, 2009). Interviews followed a phenomenological
approach of asking participants to relate specific sit-
uations where they had been involved in palliative
sedation of a patient at the hospice and how they
had felt about this. We used prompts to probe about
the types of medication used and for details on ad-
ministrative practices. Data analysis commenced
with the first interview, and no new themes were
emerging after carrying out analysis of six inter-
views. A further interview was conducted that con-
firmed saturation within seven interviews (Guest
et al., 2006), and no new themes emerged. Colaizzi’s
(1978) stages of analysis were utilized to develop
themes from the data. As per Colaizzi’s stage seven,
all participants were offered the opportunity to com-
ment on both the transcripts and then the developing
themes, but all declined. We followed the five expres-
sions from a framework for evaluating rigor in phe-
nomenology developed by de Witt and Ploeg (2006),
in tandem with Colaizzi’s stages, thus addressing
the last stage of Colaizzi’s framework, where we
drew on our own clinical experience and those of
four colleagues who had not been participants in
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the study. In our analysis, we believe we achieved a
high level of rigor using the framework of de Witt
and Ploeg (2006), where we: (1) established a balance
between the voices of study participants and our own
philosophical explanations for their experiences,
which were underpinned by the concept of a good
death; (2) followed an open and systematic process
using Colaizzi’s framework; (3) determined that the
study findings are useful to practice; and (4) found
that they resonate with the experiences of other
nurses in hospice practice, as addressed above. Actu-
alization of the findings and implications for future
practice within hospice care are addressed later in
this article.
Ethical approval for the study was obtained from
the university ethics committee and the hospice re-
search committee, and written consent was obtained
prior to each interview.
FINDINGS
Facilitating a “peaceful death” was interpreted as the
primary purpose of administering palliative sedation
to a dying person in the hospice. This interpretation
was made based on the language used by the nurses,
where they sought to enable and support patients to
be “at peace,” “settled,” “comfortable,” “relaxed,” and
“calm” as they approached death. Achieving this
state was underpinned by a number of concerns, in-
terpreted as ethical “dilemmas of care.” The dilem-
mas encountered included: medication decisions,
“juggling the drugs,” concern that they (the nurses)
had caused the death, sedating young people, re-
quests for sedation from family and patients, and rel-
atives conceptualizing hospice as a place where death
is hastened. There was a fundamental need for team
support in decision making and emotionally manag-
ing the difficult and complex situations that were en-
countered by the nurses.
Facilitating a Peaceful Death
Central to the nurses’ work in managing terminal
restlessness was the need to facilitate a “peaceful
death.” They wanted to see their patients “at peace,”
“settled,” “comfortable,” “relaxed,” and “calm,” as did
(according to the nurses) family members. These
terms were found repeatedly throughout the data, al-
ways related to the aim of the intervention.
Decision Making and Ethical and Emotional
Conflict
Medication Decisions: “Juggling the Drugs”
Dilemmas occurred most frequently in relation to de-
ciding what drugs to give. All patients referred to by
participants had terminal cancer, and midazolam
was most frequently the first-line medication given.
Concerns were often more specifically about juggling
the specific drugs and dose levels in tandem with re-
peatedly assessing the condition of the patient:
After midazolam, when you give an extra dose and
it doesn’t work, then I would give levo to help.
(N2:15–19)
All of the nurses were troubled at some stage by
whether or not they had made the right decision in
starting a particular medication:
But when he was restless and you are jumping
from one medication to— from midazolam to halo-
peridol (haloperidol was tried as well), to levome-
promazine, obviously, that was the unsettled
period when whatever we were trying was not con-
trolling the symptom, and he was still uncomfort-
able . . . that’s when we felt unsure. (N3:141–146)
Three of the nurses had the experience of administer-
ing phenobarbitone to induce deep continuous seda-
tion. When it was employed, it was the subject of
long discussions and debate within the multidisci-
plinary team. It was also reflected on at length by
the participants, both at the time they were involved
in the administration and during the interview:
We obviously excluded all the possible reasons for
him to be restless, and it was a lot of drugs that
we tried to use. We started with midazolam. . . .
He was even more agitated and restless, and we
had to use levomepromazine. In the end, he ended
up with two syringe drivers. The second syringe
driver was with phenobarbitone, quite a high
dose. He died peacefully in the end, but obviously
he was very restless before we could get the right
dose. (N3:27–31)
When using medications such as phenobarbitone, if
the time was protracted before death occurred, the
nurses started to doubt their original decision to be-
gin palliative sedation. They expressed concerns
that maybe they had missed a reversible cause of
the symptom they were trying to manage. This was
even more of a concern and dilemma when they be-
came aware of family member discomfort about the
length of time that the person remained heavily se-
dated:
He became very agitated and distressed. Despite
trying to exclude all other possible causes, it was
difficult to get on top of that symptom, and a deci-
sion was made to escalate his treatment, and he
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eventually had a syringe with phenobarbitone. He
subsequently died comfortably, but there were
some challenges throughout that end-of-life period
that might have been in excess of five days on phe-
nobarbitone driver, where certainly the daughters
became a little uncertain in their decision-making
process, which made it difficult just to be consis-
tent as a team that what we were doing was correct
and in the best interest of this patient. (N5:28–36)
‘Causing the Death’
All of the nurses expressed uncertainty that pallia-
tive sedation could or would actually lead to the
death of the patient, and they repeatedly reflected
on this possibility. They all reported experiencing
anxiety at some time about such an outcome, but
all maintained the position of wanting what was
deemed “best for the patient” at that time. The
more experienced nurses expressed higher confi-
dence in their decisions to administer palliative seda-
tion, balancing this with the aim of the intervention:
Although I would never be sure whether the med-
ications had hastened the patient’s death. I am al-
ways clear in my mind that my aim is to— is the
patient’s comfort or perhaps to control extreme ag-
itation, or distress. (N5:11–15)
We had to give this gentleman quite a large dose
of levomepromazine before we got him settled. And
he did settle. He did die afterwards, I think within
hours, which proves to me that it was very, very ter-
minal agitation. It was a very large dose of levo that
we had to give. And we did not give it all in once.
Obviously, we went in, and when it didn’t work,
we went in again. I feel that was appropriate.
(N1:45–51)
They took their responsibilities very seriously, and
all expressed concern about whether or not their ac-
tions were ethically sound. Each experience added
to their growing expertise on administration of palli-
ative sedation, and their decisions were always care-
fully considered from a number of angles and
perspectives:
I had a patient who was very frightened about dy-
ing and just wanted to be given a midazolam sy-
ringe driver for last few weeks of his life, and I
felt that that was not ethically right, as he was still
able to eat and drink, and by sedating him to that
level, we would be actually hastening his death be-
cause it would be preventing him from eating and
drinking, and he would be left in bed . . . and
more prone to chest infections, which could hasten
his death. . . . That’s always been something that
stayed in my mind. Therefore, I am very careful
about the use of the drug and don’t think that, in
most cases, in any cases really, that using midazo-
lam has hastened death. (N6:128–137)
Sedating Young People
The patient’s age was a significant factor that led to
dilemmas about using palliative sedation. Feelings
and concerns regarding the impact of palliative seda-
tion were more powerful if the dying person was
younger. All of the nurses found it more difficult to se-
date younger patients and worried that they might be
missing a reversible cause of the agitation. It was
particularly problematic if it was an unexpected
event:
I never dealt with terminal restlessness presenting
in such an aggressive way in such a young person
with such a young family and with the family being
so distraught about it. I felt anxious about admin-
istering big doses to somebody who was still young
and . . . he deteriorated very suddenly from some-
body who was able to stand and get himself to
bed . . . and in a couple of days he had a rapid disease
progression. So it made me feel anxious about ad-
ministering . . . at that point, because generally peo-
ple are probably comatose and look cachectic? . . .
but he still looked facially . . . and in his body . . .
he didn’t look that ill. That’s probably what made
me feel so different about doing it. (N4:110–120)
When the patient was younger, relatives were often
overwhelmed by the rapid changes they saw in the
dying person’s condition and behavior. These rapid
changes were frequently the reason why the patient
had been admitted to the hospice. Family members
regularly indicated their sense of helplessness and
expressed a desire for the professionals to take con-
trol of the situation:
Basically, [the patient’s wife] just wanted us to take
control of the situation. She didn’t have any great
views or opinions about what we were doing. She
was just happy she had professionals to help her
with the situation. (N1:79–82)
This sense of helplessness was also experienced by
the nurses, causing them to become cautious in their
approaches to administering palliative sedation:
I hadn’t seen that sort of thing before, and so, and
she looked terrified, absolutely terrified, and the
children were just sort of looking to me. You
know, can’t you do something? And I just felt out
of my depth. So I was going in with like 2.5
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midazolam, really scared to up it, whereas now I
wouldn’t hesitate, and if 2.5 didn’t help, then I’d
be going in with something else, but then it was
just— I just, it felt hopeless really. (N7:34–43)
It wasoften the sense ofhelplessnessand hopelessness
that led patients and families to make requests for pal-
liative sedation to be activated. However, requests re-
lated to terminal restlessness were predominantly
made by family members, as the patients themselves
were usually incapable of making such requests.
Requests for Sedation and Believing that Hospice
Was a Place Where Death Is Hastened
Care dilemmas were closely interrelated to providing
support for families as well as the patient and being
torn between having the responsibility to attend to
the needs of both. The nurses recognized the difficul-
ties faced by families, and dealing with family dis-
tress impacted on how care was managed. In many
situations, when family members said that they
just wanted their loved ones “to be comfortable,” it
was implicitly understood, and often explicitly ex-
pressed, that they wanted the patient sedated and
did not want to be exposed to their restless and agi-
tated behavior:
They were desperate for it. It wasn’t that they ha-
ven’t thought of [sedation], and we put it to them
as an idea. It was more that they were desperate.
They were so upset by seeing their loved one dis-
tressed by what was happening to him and so out
of character and so aggressive that they wanted
also what was the best thing for him, and that
was for him to be settled and out of the distress
and discomfort that he was in. They were almost
begging for us to do something . . . “please calm
him down.” (N4:81–88)
The views about hospice practice held by some rela-
tives were distressing to the nurses: “They think
that nobody ever goes home.” These related to com-
ments which intimated that family members believed
that hospice nurses can, and do, intentionally hasten
a patient’s death at times. When they had to deal with
overt requests from family members to accelerate a pa-
tient’s death, they were often shocked that the impli-
cations were that they would be prepared to actually
hasten the death:
She thought we were giving him an injection to fin-
ish him off, and I found that quite scary. When we
talked her through, she was fine, but, you know, it’s
not very nice if somebody, even just for a second,
would think that. (N1:114–116)
This was not the situation for many family members
who wanted sedation. The majority were simply re-
lieved to see their loved ones peaceful and no longer
agitated or appearing to be at risk of damaging them-
selves. This enabled them to make the most of the
time they had left with the patient:
Once he was sedated, they were actually able to
spend a lot of quality time together. They played
music that they played at their wedding, and he
was so much [more] peaceful. She laid on the bed
with him, and she slept in the room. And because
he was in this state rather than the aggressive
one, they were able to spend a few days of some
quality time together without his last day of his
life being agitated and aggressive. . . . He was set-
tled and peaceful. And they had that room so com-
fortable in there. They had a lot of time and space
together. (N4: 232–242)
However, one of the more senior nurses admitted that
she found not being able to discuss treatment options
with the patient ethically challenging. This was fre-
quently due to advanced disease causing the patient
to be unable to communicate as a result of delirium
and the agitation and disorientation that this caused:
It would become an ethical dilemma if, if you really
can’t discuss it with the patient properly, so you try
to explain it to the family, and it depends where the
family are at. We need to remember we are treating
the patient not the family. (N3, 198–201)
“Being Supported”
The importance of support when making decisions
about administering palliative sedation was heavily
emphasized. This included having opportunities to
share the decision making with team members.
They were relieved at having somebody more senior,
such as the ward manager or a palliative consultant,
confirm that administering sedation was the right
decision to make. It was seen as part of the suppor-
tiveness of working with an experienced palliative
care team:
It was so upsetting as well to nurse a man and his
family through such a difficult time. It was felt
through the whole ward really. So the manager
was always around offering support . . . very ap-
proachable and offering reassurance as well that
we were doing everything for the best of the pa-
tient. (N2:134–140)
One newly qualified nurse admitted to being very
frustrated when she felt out of her depth and could
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not find anybody on the ward to talk to, from whom to
seek advice:
Because I wasn’t getting anywhere with what I
was giving her, I was, like I say, I was out of my
depth at that time . . . it was one of those occasions
where I needed a lot of reflection because I felt I let
her down because of my inexperience. (N7:63–64,
92–93)
Being praised for “doing a good job” was also per-
ceived by the nurses as a form of support. It reas-
sured them that their actions were acknowledged
and approved regardless of whether it came from
the management or the relatives, or it was stated
during reflective practice sessions:
[The palliative care team] felt that I had done a
good, as good job as I could and were appreciative
for what I had done, so that was— that made me
feel better about it. I felt upset about it, but I think
they felt I had done my best. I know I shouldn’t
think about how I feel, but actually somehow it
made it better for me afterwards. (N6:102–106)
DISCUSSION
The key finding of our study was that the nurses be-
lieved that administration of palliative sedation facil-
itated a “peaceful death” for dying patients. However,
achieving this led to “dilemmas of care” for the nurses
concerned. Our finding that the nurses wanted to see
their patients “at peace,” “settled,” “comfortable,” “re-
laxed,” and “calm” is in keeping with the findings of
Zinn and Moriarty (2012), in that hospice nurses be-
lieved patients suffered and were rendered peaceful
by palliative sedation.
The concept of a peaceful death is concordant with
that of the “good death,” a term that has been central
to the hospice movement (Hart et al., 1998) and is a
subject that has attracted a number of research pro-
jects and considerable philosophical dialogue. There
has been criticism of attempts to establish what could
be considered a good death due to the vast diversity of
individual values and preferences and a growing con-
sensus that a good death is something that cannot be
defined beforehand in general terms and is not the
same for everyone (Goldsteen et al., 2006, McNa-
mara, 2004). We acknowledge the above (and many
other) discussions on this concept and also the claim
by Scarre (2012) that the expression “good death” is
necessarily an oxymoron. However, the “peaceful
death” referred to by the nurses was consistent
with the more pragmatic conceptualization of good
and bad deaths by Low and Payne (1996), for whom
a “good” death was deemed to be adequate symptom
management resulting in a patient’s comfort and
lack of family distress, while a “bad” death was the re-
sult of uncontrolled symptoms, lack of acceptance, or
being young.
All of the patients discussed by the participants
had cancer, confirming that this patient group is
the most likely to receive palliative sedation (Swart
et al., 2012). Medications that were used were consis-
tent with those identified in the literature as most
likely to be utilized by specialist palliative clinicians.
All of the nurses demonstrated knowledge and exper-
tise in the range of medications used and their effica-
cy in palliative sedation. The medication that caused
a significant dilemma was phenobarbitone, which is
an anticonvulsant mainly used in intensive care
units to induce long-term sedation to enable mechan-
ical ventilation. The rarity of the use of phenobarbi-
tone in hospice (Gillon et al., 2010; Cheng et al.,
2002) was reflected in the concerns expressed by
nurses when administering it.
Managing terminal restlessness in patients with
advanced disease is essential. Some even describe it
as a “moral imperative” and argue that there is no
need for it to be such an ethically controversial issue
(Kohara et al., 2005). This does not lessen the emo-
tions experienced by those who are closely involved
in making decisions, interacting closely with the pa-
tients and family members and actually administer-
ing the medications (Morita et al., 2004; Zinn &
Moriarty, 2012; Rau et al., 2014). Brajtman (2003)
found that families experienced multidimensional
suffering and could be ambivalent about sedating
medications, feeling that they “were being pulled in
two different directions” (p. 457). They wanted the
patient’s suffering to end but also wanted to continue
to be able to communicate with them (Brajtman,
2003). These were reactions reported by the nurses
in our study, although there was emphasis on the
family desire for sedation rather than not. Our data
also revealed a strong focus on experiences related
to decision-making dilemmas specific to the type of
medications that were used rather than perceptions
about the experiences of family members, which
was the focus of the participants in the Zinn and Mor-
iarty study (2012). This is perhaps a reflection of the
details of what and how medications were used that
we asked about during interviews.
Some relatives were reported as holding views
about hospice practice that were shocking and unex-
pected—that is, the belief that hospice nurses can,
and do, intentionally hasten a patient’s death at
times. This was the conclusion drawn by Seymour
et al. (2007), who found that U.K. clinicians (nurses
included) had to deal with “paradoxical and poten-
tially contradictory cultural meanings associated
with the methods used to relieve suffering”
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(p. 1683). As also found in our study, in some instanc-
es the nurses found that the act of administering se-
dation for terminal restlessness was interpreted as
“attempts to hasten death” (Seymour et al., 2007).
Dealing every day with dying people requires ex-
ceptional personal qualities. However, Kulbe (2001)
argues that even the nurses in possession of those
qualities are affected by the emotional burden of
their work and are at risk of burnout, which will af-
fect the quality of care they provide. The hospice
movement is well known for its supportiveness to-
ward patients, their families, and friends as well as
staff. Support is particularly strong in relation to
making difficult and ethically challenging decisions
where sharing knowledge and support are seen as
important components of an effectively working
healthcare team (Kirklin, 2010; Fillion et al., 2007).
The nurses in our study generally felt supported by
the hospice team in decision making and in emotion-
ally managing the difficult and complex situations
that they encountered when administering palliative
sedation. Furthermore, there was a recognition that
high-level decision making required experience, spe-
cialist skills, and consultation with team members, a
finding upheld by other research (Mercadante et al.,
2009; de Graeff & Dean, 2007; Seymour et al., 2007;
Dean et al., 2014).
LIMITATIONS
This qualitative study included a small purposive
sample of palliative care nurses practicing in one hos-
pice unit. Nurses provide end-of-life care in multiple
settings, and, as each setting has its unique charac-
teristics, the results of our study do not reflect the ex-
periences of all nurses caring for terminally patients
and their families. Further, there were a number of
challenges that were only touched on in the inter-
views and that require further exploration—for ex-
ample, the concerns expressed by one of the more
senior nurses regarding not being able to discuss
treatment options with patients who had terminal
restlessness.
IMPLICATIONS FOR PRACTICE AND
FUTURE RESEARCH
Despite its limitations, there are a number of impli-
cations for practice and future research that emerge
from our study. Primarily, hospice nurses need to be
confident, competent, and well supported within an
expert palliative care team when faced with making
decisions about the use of palliative sedation. Al-
though hospice palliative care is often carried out in
a multi/interprofessional environment, discussions
during team meetings do not always include staff at-
titudes toward palliative sedation. Strong leadership
is needed to facilitate a supportive culture where the
complexity of dealing with ethical concerns is ad-
dressed. The importance of palliative care skills and
the requirement that professionals be skilled in
both symptom control and end-of-life care were iden-
tified in our study and are in keeping with contempo-
rary research in the field. However, the part played by
nurses in these processes is poorly understood. In ad-
dition, patient consent for terminal sedation has high
priority in published guidelines, to the extent that
recommendations are that terminal sedation should
not be instigated under any condition where consent
has not been obtained from the patient. The complex-
ity of engaging in discussions with patients and their
families from all angles, including gaining consent,
requires further exploration.
CONCLUSION
Hospice nurses frequently encountered ethical and
emotional dilemmas when making decisions about
and administering palliative sedation. In the United
Kingdom, a hospice nurse is frequently the primary
clinician who engages in discussions about symptom
management with patients and families and is also
the clinician who administers the palliative sedation
medication. Our study demonstrates that hospice
nurses are regularly faced with the responsibility of
making decisions about complex symptom manage-
ment and medication regimes when administering
palliative sedation. Making such decisions requires
confidence on the part of the nurses as well as good
communication and sound supportive teamwork
within the hospice.
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